The Prix Galien internationally stands as the industry equivalent of the Nobel Prize in medical innovation.
Initially, the award originated in France, but thanks to the growing dedication of numerous companies to biomedical research and development, this esteemed prize is now granted in 15 different countries.
In Belgium, Artsenkrant/Le Journal du Médecin is the driving force behind the Prix Galien propelling innovation in the Belgian healthcare sector!
Since last year, the award has been divided into two events. The Prix Galien Medical Devices on 14 March 2024 and the Prix Galien pharmaceuticals that takes place on 21 May 2024.
This year’s Prix Galien for Medical Devices was awarded to IDEVAX and Intressa Vascular. The award for most innovative medical device went to VAX-ID® developed by IDEVAX and Intressa Vascular won the award for most promising design with their Allay®Aortic Stent. We would like to give special thanks to our partners COVARTIM and beMedTech.
Interessted in registering your innovation in Medical Design or Pharmaceuticals?
THE PRIZE IS PRESENTED IN FOUR DISTINCT CATEGORIES:
Medical Devices
The most innovative medical device, honours a medical device that can lead to better treatment
The most promising design, dedicated to a young company showcasing an innovative product
Pharmaceuticals
The best pharmaceutical agent, reserved for the most groundbreaking pharmaceutical innovation.
The best pharmacological research project, acknowledging the contributions of a researcher or a group of researchers in the realm of clinical studies and/or fundamental research.